Back to LCTX
Hofer & Associates. Inc → LCTX
Hofer & Associates. Inc LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
1
Latest value
$484K
Q3 2026
Peak value
$484K
First seen
Q3 2026
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $484K | 506.5K | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M